NR 536 Week 3 Developing Critical Thinking Questions

Student Name

Chamberlain University

NR-536: Advanced Health Assessment, Pathophysiology & Pharmacology for Advanced Nursing Practice

Prof. Name

Date

Week 3 Assignment: Developing Critical Thinking Questions

Concept to be Presented: Protection and Movement – Infections

This week’s assignment highlights the development of critical thinking questions centered on the theme of protection and movement, with a particular focus on infections such as ventilator-associated pneumonia (VAP). The selected learner for this exercise is a staff nurse employed in an acute care hospital, who has accumulated three years of clinical experience in infection management and patient safety. Strengthening the nurse’s critical thinking capacity is essential for improving patient outcomes, especially in infection prevention and the management of hospital-acquired conditions.

Problem Recognition

A 65-year-old male patient was admitted to the hospital due to chest pain and was later diagnosed with localized pleuritis. Within this healthcare facility, the reported rate of hospital-acquired pneumonia (HAP) is 3.8%, which indicates a substantial risk for VAP in mechanically ventilated patients. The primary clinical objective is to lower infection rates by implementing effective prevention strategies to avoid the onset of VAP and enhance patient care quality.

Table 1: Critical Thinking Questions for Problem Recognition

Pathophysiology	Physical Assessment	Pharmacology
Question: What are the underlying reasons for the elevated VAP rates in this healthcare setting? Answer: Several factors contribute, including inadequate infection control, insufficient oral hygiene practices, limited hand hygiene compliance, and improper ventilator positioning. Frequent antibiotic use and aspiration events further elevate risk (Hua et al., 2016; Khan et al., 2017).	Question: What physical assessment practices are essential to reduce bacterial accumulation in the respiratory tract? Answer: Nurses should routinely evaluate lung sounds, monitor airway patency, and assess secretion volume. Assessments every 24–48 hours help detect early infection signs and guide timely interventions (Álvarez-Lerma et al., 2018).	Question: Has antimicrobial resistance contributed to rising VAP incidence? Answer: Yes. The overuse and inappropriate selection of antibiotics have led to resistant bacterial strains, especially in older patients, increasing susceptibility to VAP (Zampieri et al., 2015).

Clinical Decision Making

To mitigate the threat of VAP, the hospital implemented a VAP prevention bundle. This evidence-based practice package is designed to minimize infection risk, shorten hospitalization, and lower treatment costs. Adoption of the bundle underscores the importance of combining pathophysiological understanding, thorough physical assessment, and judicious pharmacological strategies in clinical decisions.

Table 2: Critical Thinking Questions for Clinical Decision Making

Pathophysiology	Physical Assessment	Pharmacology
Question: What evidence supports the use of the VAP prevention bundle? Answer: Clinical research demonstrates that bundled interventions, such as head-of-bed elevation, daily sedation breaks, and improved oral care, significantly reduce VAP rates and improve patient safety outcomes (Álvarez-Lerma et al., 2018; Pinho et al., 2020).	Question: When should patient assessments ideally occur to identify early respiratory complications? Answer: Assessments should be conducted within the first 24 hours of intubation and repeated regularly, as the risk of VAP escalates after 48 hours of ventilation (Fortaleza et al., 2020).	Question: How does an extended hospital stay affect the efficacy of the VAP prevention bundle? Answer: Longer hospitalizations often correlate with increased antibiotic resistance and a higher risk of superinfections. Studies suggest that combining the bundle with probiotic use may enhance protective effects (Xie et al., 2019; Zhao et al., 2020).

Prioritization and Clinical Intervention

The care team determined that continuous monitoring within the first 24 hours was a priority intervention to lower VAP risks. Nursing workload and stress were also considered in intervention planning. To strengthen outcomes, multimodal interventions such as sedation management, regular repositioning, and early mobility were integrated into patient care.

Table 3: Critical Thinking Questions for Prioritization and Clinical Intervention

Pathophysiology	Physical Assessment	Pharmacology
Question: What early warning signs suggest that a patient requires closer monitoring for VAP? Answer: Initial symptoms include fever, changes in respiratory rate, adventitious breath sounds, oxygen desaturation, and sputum production. Prompt recognition of these signs is critical for initiating advanced care measures (Álvarez-Lerma et al., 2018).	Question: What ventilator positioning helps reduce infection risk? Answer: Elevating the head of the bed to approximately 30 degrees minimizes aspiration and supports better lung expansion. This intervention, paired with consistent oral care, reduces bacterial colonization (Fortaleza et al., 2020).	Question: Should chlorhexidine be prioritized over standard oral hygiene practices? Answer: Evidence suggests that chlorhexidine (0.2%) can lower bacterial load, but some studies raise concerns regarding cytotoxic effects. Therefore, chlorhexidine should be used selectively, supplemented by routine oral care practices (Prasad et al., 2019; Vieira et al., 2020).

References

Álvarez-Lerma, F., et al. (2018). Prevention of ventilator-associated pneumonia. Critical Care Medicine, 46(2), 181–188. https://doi.org/10.1097/ccm.0000000000002736

Bardia, A., et al. (2019). Preoperative chlorhexidine mouthwash to reduce pneumonia after cardiac surgery: A systematic review and meta-analysis. The Journal of Thoracic and Cardiovascular Surgery, 158(4), 1094–1100. https://doi.org/10.1016/j.jtcvs.2019.01.014

NR 536 Week 3 Developing Critical Thinking Questions

Fortaleza, C., et al. (2020). Sustained reduction of healthcare-associated infections after the introduction of a bundle for prevention of ventilator-associated pneumonia in medical-surgical intensive care units. The Brazilian Journal of Infectious Diseases, 24(5), 373–379. https://doi.org/10.1016/j.bjid.2020.08.004

Hellyer, T., et al. (2016). The intensive care society recommended bundle of interventions for the prevention of ventilator-associated pneumonia. Journal of the Intensive Care Society, 17(3), 238–243. https://doi.org/10.1177/1751143716644461

Hua, F., et al. (2016). Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd008367.pub3

Khan, Z., et al. (2017). Ventilator-associated pneumonia or ventilator-induced pneumonia. Multidisciplinary Respiratory Medicine, 12, 224. https://doi.org/10.4081/mrm.2017.224

Olanipekun, T., & Snyder, R. (2019). Mortality risk in ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia. Critical Care Medicine, 47(10), e851–e852. https://doi.org/10.1097/ccm.0000000000003662

Pinho, R., et al. (2020). Impact of each component of a ventilator bundle on preventing ventilator-associated pneumonia and lower respiratory infection. Infection Control & Hospital Epidemiology, 41(S1), s259–s260. https://doi.org/10.1017/ice.2020.824

NR 536 Week 3 Developing Critical Thinking Questions

Prasad, R., et al. (2019). The impact of 0.2% chlorhexidine gel on oral health and the incidence of pneumonia amongst adults with profound complex neurodisability. Special Care in Dentistry, 39(5), 524–532. https://doi.org/10.1111/scd.12414

Vieira, P., et al. (2020). Should oral chlorhexidine remain in ventilator-associated pneumonia prevention bundles? Medicina Intensiva. https://doi.org/10.1016/j.medin.2020.09.009

Xie, X., et al. (2019). Drug prevention and control of ventilator-associated pneumonia. Frontiers in Pharmacology, 10, 298. https://doi.org/10.3389/fphar.2019.00298

Zampieri, F., et al. (2015). Nebulized antibiotics for ventilator-associated pneumonia: A systematic review and meta-analysis. Critical Care, 19, 86. https://doi.org/10.1186/s13054-015-0868-y

Zhao, J., et al. (2020). Do probiotics help prevent ventilator-associated pneumonia in critically ill patients? A systematic review with meta-analysis. ERJ Open Research, 6(2), 00302–2020. https://doi.org/10.1183/23120541.00302-2020